.@aditxt $ADTX Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 #StocksToWatch #stocksinnews #investors #smallcaps businesswire.com/news/home/2…

.@aditXt (Nasdaq: $ADTX), Inc. Regains Compliance with Nasdaq Listing Requirements #stockstowatch #stocksinnews #investor #daytrader finance.yahoo.com/news/aditx…

.@aditxt $ADTX Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk finance.yahoo.com/news/aditx… #Cancer #investors

Join Aditxt’s (NASDAQ:ADTX) Fireside Chat Friday, Feb 21 @ 11:30 AM ET CEO Amro Albanna will provide company update including key developments across Adimune, Pearsanta, and upcoming initiatives. Submit Qs by Feb 20 5PM ET: [email protected] us06web.zoom.us/webinar/regi…

🌍 In South Sudan, girls are more likely to die in childbirth than finish school. 300K maternal deaths in 2020 @DFID_UK reports. @Evofem's Phexxi® leads in non-hormonal contraception, empowering women's reproductive health. lnkd.in/gvm543gD

Final Call to Join Our Investor Event Today! Amro Albanna will provide an overview of our plans for 2024 and the promising innovations showcasing our commitment to tackling complex health challenges. Don't miss this chance to be a part of our journey. Last chance to register here: redchip.zoom.us/webinar/regi…

Today is a day to celebrate Dr. Martin Luther King Jr. and his impact on civil rights and social justice. We also recognize that his actions and methods were a form of innovation within the social context of his time. His foresight in combining moral vision with strategic action reminds us that innovation is not solely the domain of technology, science, business, etc. it is deeply rooted in an approach to solving societal challenges. #MartinLutherKingDay #InnovationForEquity #ReflectingOnLegacy

You don’t wear a car seat belt for protection when you’re not in a car…. Why daily birth control? Since 1960, that's been the norm, but every day isn't 'that day'. Meet Phexxi: The birth control revolution! Take charge only when needed - say goodbye to daily doses! Time for smarter choices in women's health. Discover more about the on-demand, non-hormonal contraception at Phexxi.com #Evofem is innovating for women's choice and empowerment worldwide. #WomenInControl #AditxtSupports #PhexxiForward #Empowerment #ReproductiveHealth #ChoiceMatters #BirthControlRevolution #RoevWade #myrightmydecision

Shocking data from @UNFPA Almost half of all global pregnancies (121M annually) are unintended. Innovation is crucial in addressing this. Enter @Evofem Phexxi: Empowering women with reproductive health choices. We're committed to Phexxi's success, enhancing accessibility & empowering women worldwide. #PhexxiForward #Aditxt #WomensHealth #HealthcareInnovation #EmpoweringWomen #FemTech #UnitedNations

Aditxt’s recently signed a definitive agreement to acquire @Evofem in a $100M transaction. We’re thrilled to re-share their news that Phexxi, a hormone-free contraceptive, is now available on Washington Medicaid plans without Prior Authorization. This change affects 1.8 million lives, enhancing reproductive choices in Washington. More details here: prnewswire.com/news-releases… #phexxiforward #womenshealth #PhexxiCoverage #WashingtonHealthcare

Aditxt subsidiary Pearsanta acquires MDNA's Mitomic™ Platform for $25M! Aiming at major strides in women's & men's health, and entering the booming liquid biopsy market. 🧬 Key Features: Precision diagnostics using mitochondrial DNA. Early, non-invasive disease detection. Impact: Expanding in cancer detection. Innovating in health tech. Leader Insights & more: businesswire.com/news/home/2….’s-Subsidiary-Pearsanta-Inc.-Acquires-MDNA-Life-Sciences-Inc.’s-Proprietary-Mitomic™-Testing-Platform-Pioneering-Early-Disease-and-Cancer-Detection-in-a-Transaction-Valued-at-Approximately-25-Million #Aditxt #Pearsanta #HealthcareInnovation #LiquidBiopsy #CancerDetection

We're driven to innovate for life-changing solutions. But it's stories like Kayla's, battling lung transplantation, that truly highlight our mission. Her journey is a poignant example of the lives we touch & the urgency of our work. That's our motivation every day. To make a difference, to push through challenges. Because at the end of the data point, there's a human story, a person and their family waiting for hope & good news. #Transplantation #LungTransplant #Adimune #Innovation #InnovationInHealthcare #InnovationInHealth

We've recently announced we have signed a Definitive Agreement to acquire @Evofem creators of Phexxi - the ONLY FDA-approved, non-hormonal contraceptive gel for women. If you haven’t seen their CEO’s @TEDxSanDiego presentation, it’s a must-watch! Saundra's informative presentation challenges norms and ignites vital discussions on women's health choices. Saundra asks, "If chickens can be hormone-free, why can't women?" A powerful call for hormone-free options in women's health. Join us in shaping a future where women have more choices in healthcare. Let's drive this change together! youtube.com/watch?v=7ypxK7pK… #PhexxiForward #Innovation #WomensReproductiveHealth #HealthcareInnovation #EmpoweringChoices #FutureOfHealth

Thanks to @mariaaspan from @FortuneMagazine for speaking with Amro & Saundra from @Evofem about the recent announcement. We recognize Evofem's incredible potential, we're committed to ensuring its sustained success as a promising innovation, expanding accessibility to women worldwide. #Phexxiforward #WomensHealth #WomenRights #WomensEmpowerment #ReproductiveHealth fortune.com/2023/12/13/evofe…

Exciting news at Aditxt (NASDAQ: ADTX)! 🚀 We're thrilled to share that we’ve signed a definitive agreement to acquire @Evofem Biosciences, Inc., makers of Phexxi®—the only FDA-approved hormone-free contraceptive gel. Phexxi empowers women in a revolutionary way. This on-demand gel, applied within an hour before intercourse, gives women autonomy over their reproductive health. businesswire.com/news/home/2…®-the-First-and-Only-FDA-Approved-Hormone-Free-Contraceptive-Gel-to-Address-Diverse-Reproductive-Health-Needs-of-Women-Globally Join our journey! Like, share, and let's talk #Phexxiforward. Together, let's make a difference.

A ‘bionic pancreas’ that combines an insulin pump and automated dosing software has been approved by the US Food and Drugs Administration (FDA) for use by people living with #TypeOne diabetes in the US. tinyurl.com/yv7nuh2e #Innovation

"When you are in foreign country, it can be difficult to navigate the healthcare and insurance system of the country you are visiting or working in." Read how @Medinaction has innovated to provide services for those in need. Via @Forbes tinyurl.com/3fuzcfud #HealthCare